1. Home
  2. RCKT vs CNMD Comparison

RCKT vs CNMD Comparison

Compare RCKT & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • CNMD
  • Stock Information
  • Founded
  • RCKT 1999
  • CNMD 1970
  • Country
  • RCKT United States
  • CNMD United States
  • Employees
  • RCKT N/A
  • CNMD N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • RCKT Health Care
  • CNMD Health Care
  • Exchange
  • RCKT Nasdaq
  • CNMD Nasdaq
  • Market Cap
  • RCKT 328.6M
  • CNMD 1.7B
  • IPO Year
  • RCKT N/A
  • CNMD 1987
  • Fundamental
  • Price
  • RCKT $3.16
  • CNMD $52.91
  • Analyst Decision
  • RCKT Buy
  • CNMD Hold
  • Analyst Count
  • RCKT 13
  • CNMD 5
  • Target Price
  • RCKT $12.96
  • CNMD $59.80
  • AVG Volume (30 Days)
  • RCKT 5.7M
  • CNMD 322.7K
  • Earning Date
  • RCKT 11-06-2025
  • CNMD 10-29-2025
  • Dividend Yield
  • RCKT N/A
  • CNMD 1.51%
  • EPS Growth
  • RCKT N/A
  • CNMD 12.82
  • EPS
  • RCKT N/A
  • CNMD 3.54
  • Revenue
  • RCKT N/A
  • CNMD $1,326,244,000.00
  • Revenue This Year
  • RCKT N/A
  • CNMD $6.73
  • Revenue Next Year
  • RCKT $108.43
  • CNMD $5.45
  • P/E Ratio
  • RCKT N/A
  • CNMD $14.94
  • Revenue Growth
  • RCKT N/A
  • CNMD 3.94
  • 52 Week Low
  • RCKT $2.19
  • CNMD $46.00
  • 52 Week High
  • RCKT $22.01
  • CNMD $78.19
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 46.82
  • CNMD 47.69
  • Support Level
  • RCKT $3.12
  • CNMD $52.35
  • Resistance Level
  • RCKT $3.30
  • CNMD $54.12
  • Average True Range (ATR)
  • RCKT 0.18
  • CNMD 1.42
  • MACD
  • RCKT -0.02
  • CNMD -0.19
  • Stochastic Oscillator
  • RCKT 6.46
  • CNMD 19.26

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.

Share on Social Networks: